Invention Grant
- Patent Title: Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors
-
Application No.: US16546328Application Date: 2019-08-21
-
Publication No.: US10774077B2Publication Date: 2020-09-15
- Inventor: Jean-Louis Reymond , Simon Nicolussi , Jurg Gertsch
- Applicant: UNIVERSITAT BERN
- Applicant Address: CH Bern
- Assignee: UNIVERSITAT BERN
- Current Assignee: UNIVERSITAT BERN
- Current Assignee Address: CH Bern
- Agency: JMB Davis Ben-David
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4ace4b55 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6c723a02
- Main IPC: C07D277/20
- IPC: C07D277/20 ; C07D417/06 ; C07D277/54
Abstract:
The invention relates to a compound comprising the following general formula (1): and said compound for use as a medicament, in particular for use in the treatment psychiatric or neurological disorders and inflammation, in particular neuroinflammation: (formula 1) wherein each of R1, R2 and R3 are selected independently from each other from alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, aryl, heterocycle, or heteroaryl.
Public/Granted literature
Information query
